Pharmaceutically useful sulfur containing heterocyclic derivativ

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424276, A61K 3138, A61K 3139

Patent

active

039378357

ABSTRACT:
Compounds of the following general formula are useful in the treatment of conditions of delayed hypersensitivity. ##SPC1##
Wherein X represents a bond, --CH.sub.2 --, or oxygen; Y represents a vinlyene group, --CH(OH)--, carbonyl, oxygen, divalent sulfur, or carbonyloxy with the proviso that when Y is oxygen, divalent sulfur or carbonyloxy, X represents a bond; A represents a straight or branched alkylene chain of from 1 to 6 carbon atoms with the proviso that when Y is vinlyene, A contains from 1 to 5 carbon atoms; and with the proviso that when Y is carbonyloxy, A contains from 2 to 6 carbon atoms; each of R.sup.1 and R.sup.2 is selected from hydrogen, a straight or branched lower alkyl group of from 1 to 4 carbon atoms; or alkenyl of 3 to 6 carbon atoms having the vinyl unsaturation in other than the 1-position, and pharmaceutically acceptable acid addition salts thereof.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutically useful sulfur containing heterocyclic derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically useful sulfur containing heterocyclic derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically useful sulfur containing heterocyclic derivativ will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-150467

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.